PDL BioPharma (PDLI) Concludes Strategic Review; Will Focus on Discovery and Development
Tweet Send to a Friend
After being halted just after the market closed, PDL BioPharma, Inc. (Nasdaq: PDLI) today announced that following a strategic review ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
